LacriJet® is FCI’s latest and exclusive preloaded and self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction, and canalicular laceration. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. LacriJet® has been specifically designed to reduce operating time in both the intubation phase and the removal of the device.
LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head. No nasal retrieval, knots or sutures are needed.
The 15 mm and 20 mm LacriJet® have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.
Main characteristics :
• Indicated for the treatment of congenital nasolacrimal duct obstruction, canalicular laceration, and epiphora in patients 12 months and older
• Exclusive new injection system
• Silicone tube preloaded inside the metallic guide
• No nasal retrieval
• No knots or sutures needed
• 3 mm plug collarette
• Sterile, Single use